211 related articles for article (PubMed ID: 33382513)
41. An adaptive model for rapid and direct estimation of extravascular extracellular space in dynamic contrast enhanced MRI studies.
Dehkordi AN; Kamali-Asl A; Ewing JR; Wen N; Chetty IJ; Bagher-Ebadian H
NMR Biomed; 2017 May; 30(5):. PubMed ID: 28195664
[TBL] [Abstract][Full Text] [Related]
42. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
43. GAN and dual-input two-compartment model-based training of a neural network for robust quantification of contrast uptake rate in gadoxetic acid-enhanced MRI.
Simeth J; Cao Y
Med Phys; 2020 Apr; 47(4):1702-1712. PubMed ID: 31997391
[TBL] [Abstract][Full Text] [Related]
44. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
[TBL] [Abstract][Full Text] [Related]
45. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
[TBL] [Abstract][Full Text] [Related]
46. Artificial Neural Networks approach to pharmacokinetic model selection in DCE-MRI studies.
Mohammadian-Behbahani MR; Kamali-Asl AR
Phys Med; 2016 Dec; 32(12):1543-1550. PubMed ID: 27876537
[TBL] [Abstract][Full Text] [Related]
47. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
48. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
[TBL] [Abstract][Full Text] [Related]
49. Task-based assessment of a convolutional neural network for segmenting breast lesions for radiomic analysis.
Spuhler KD; Ding J; Liu C; Sun J; Serrano-Sosa M; Moriarty M; Huang C
Magn Reson Med; 2019 Aug; 82(2):786-795. PubMed ID: 30957936
[TBL] [Abstract][Full Text] [Related]
50. Characterizing Errors in Pharmacokinetic Parameters from Analyzing Quantitative Abbreviated DCE-MRI Data in Breast Cancer.
Slavkova KP; DiCarlo JC; Kazerouni AS; Virostko J; Sorace AG; Patt D; Goodgame B; Yankeelov TE
Tomography; 2021 Jun; 7(3):253-267. PubMed ID: 34201654
[TBL] [Abstract][Full Text] [Related]
51. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors.
Kitamoto E; Chikui T; Kawano S; Ohga M; Kobayashi K; Matsuo Y; Yoshiura T; Obara M; Honda H; Yoshiura K
Acad Radiol; 2015 Feb; 22(2):210-6. PubMed ID: 25442795
[TBL] [Abstract][Full Text] [Related]
52. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
53. Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge.
Huang W; Li X; Chen Y; Li X; Chang MC; Oborski MJ; Malyarenko DI; Muzi M; Jajamovich GH; Fedorov A; Tudorica A; Gupta SN; Laymon CM; Marro KI; Dyvorne HA; Miller JV; Barbodiak DP; Chenevert TL; Yankeelov TE; Mountz JM; Kinahan PE; Kikinis R; Taouli B; Fennessy F; Kalpathy-Cramer J
Transl Oncol; 2014 Feb; 7(1):153-66. PubMed ID: 24772219
[TBL] [Abstract][Full Text] [Related]
54. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
[TBL] [Abstract][Full Text] [Related]
55. Effects of flip angle uncertainty and noise on the accuracy of DCE-MRI metrics: comparison between standard concentration-based and signal difference methods.
Wang P; Xue Y; Zhao X; Yu J; Rosen M; Song HK
Magn Reson Imaging; 2015 Jan; 33(1):166-73. PubMed ID: 25311569
[TBL] [Abstract][Full Text] [Related]
56. DCE-MRI protocol for constraining absolute pharmacokinetic modeling errors within specific accuracy limits.
Knight SP; Meaney JF; Fagan AJ
Med Phys; 2019 Aug; 46(8):3592-3602. PubMed ID: 31148187
[TBL] [Abstract][Full Text] [Related]
57. Blood-Brain Barrier Disruption in Mild Traumatic Brain Injury Patients with Post-Concussion Syndrome: Evaluation with Region-Based Quantification of Dynamic Contrast-Enhanced MR Imaging Parameters Using Automatic Whole-Brain Segmentation.
Yoen H; Yoo RE; Choi SH; Kim E; Oh BM; Yang D; Hwang I; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Jan; 22(1):118-130. PubMed ID: 32783413
[TBL] [Abstract][Full Text] [Related]
58. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
[TBL] [Abstract][Full Text] [Related]
59. Bayesian pharmacokinetic modeling of dynamic contrast-enhanced magnetic resonance imaging: validation and application.
Mittermeier A; Ertl-Wagner B; Ricke J; Dietrich O; Ingrisch M
Phys Med Biol; 2019 Sep; 64(18):18NT02. PubMed ID: 31404913
[TBL] [Abstract][Full Text] [Related]
60. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
